Drug Shortage Report for APO-CANDESARTAN

Last updated on 2021-06-14 History
Report ID 118761
Drug Identification Number 02365367
Brand name APO-CANDESARTAN
Common or Proper name CANDESARTAN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-02
Estimated end date 2021-07-02
Actual end date 2021-06-11
Shortage status Resolved
Updated date 2021-06-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-06-24 English Compare
v2 2021-03-05 English Compare
v3 2021-03-05 French Compare
v4 2021-03-17 English Compare
v5 2021-03-17 French Compare
v6 2021-04-16 English Compare
v7 2021-04-16 French Compare
v8 2021-06-02 English Compare
v9 2021-06-02 French Compare
v10 2021-06-14 English Compare
v11 2021-06-14 French Compare

Showing 1 to 11 of 11